Annual EBITDA
-$34.56 M
-$7.19 M-26.29%
December 31, 2023
Summary
- As of March 10, 2025, ANRO annual EBITDA is -$34.56 million, with the most recent change of -$7.19 million (-26.29%) on December 31, 2023.
- During the last 3 years, ANRO annual EBITDA has fallen by -$25.63 million (-286.73%).
- ANRO annual EBITDA is now -286.73% below its all-time high of -$8.94 million, reached on December 1, 2021.
Performance
ANRO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$16.31 M
-$742.00 K-4.77%
September 30, 2024
Summary
- As of March 10, 2025, ANRO quarterly EBITDA is -$16.31 million, with the most recent change of -$742.00 thousand (-4.77%) on September 30, 2024.
- Over the past year, ANRO quarterly EBITDA has stayed the same.
- ANRO quarterly EBITDA is now -137.30% below its all-time high of -$6.87 million, reached on March 1, 2023.
Performance
ANRO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$55.60 M
-$7.60 M-15.82%
September 30, 2024
Summary
- As of March 10, 2025, ANRO TTM EBITDA is -$55.60 million, with the most recent change of -$7.60 million (-15.82%) on September 30, 2024.
- Over the past year, ANRO TTM EBITDA has stayed the same.
- ANRO TTM EBITDA is now -636.00% below its all-time high of -$7.55 million, reached on December 1, 2022.
Performance
ANRO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANRO EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -26.3% | 0.0% | 0.0% |
3 y3 years | -286.7% | -137.3% | -285.4% |
5 y5 years | -286.7% | -137.3% | -285.4% |
ANRO EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -286.7% | at low | -137.3% | at low | -636.0% | at low |
5 y | 5-year | -286.7% | at low | -137.3% | at low | -636.0% | at low |
alltime | all time | -286.7% | at low | -137.3% | at low | -636.0% | at low |
Alto Neuroscience EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$16.31 M(+4.8%) | -$55.60 M(+15.8%) |
Jun 2024 | - | -$15.57 M(+20.0%) | -$48.01 M(+18.1%) |
Mar 2024 | - | -$12.97 M(+20.7%) | -$40.66 M(+17.6%) |
Dec 2023 | -$34.56 M | -$10.75 M(+23.3%) | -$34.56 M(+10.2%) |
Sep 2023 | - | -$8.71 M(+6.0%) | -$31.37 M(+38.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | -$8.22 M(+19.6%) | -$22.65 M(+57.0%) |
Mar 2023 | - | -$6.87 M(-9.0%) | -$14.43 M(+91.0%) |
Dec 2022 | -$27.37 M(+206.2%) | - | - |
Dec 2022 | - | -$7.55 M | -$7.55 M |
Dec 2021 | -$8.94 M | - | - |
FAQ
- What is Alto Neuroscience annual EBITDA?
- What is the all time high annual EBITDA for Alto Neuroscience?
- What is Alto Neuroscience annual EBITDA year-on-year change?
- What is Alto Neuroscience quarterly EBITDA?
- What is the all time high quarterly EBITDA for Alto Neuroscience?
- What is Alto Neuroscience quarterly EBITDA year-on-year change?
- What is Alto Neuroscience TTM EBITDA?
- What is the all time high TTM EBITDA for Alto Neuroscience?
- What is Alto Neuroscience TTM EBITDA year-on-year change?
What is Alto Neuroscience annual EBITDA?
The current annual EBITDA of ANRO is -$34.56 M
What is the all time high annual EBITDA for Alto Neuroscience?
Alto Neuroscience all-time high annual EBITDA is -$8.94 M
What is Alto Neuroscience annual EBITDA year-on-year change?
Over the past year, ANRO annual EBITDA has changed by -$7.19 M (-26.29%)
What is Alto Neuroscience quarterly EBITDA?
The current quarterly EBITDA of ANRO is -$16.31 M
What is the all time high quarterly EBITDA for Alto Neuroscience?
Alto Neuroscience all-time high quarterly EBITDA is -$6.87 M
What is Alto Neuroscience quarterly EBITDA year-on-year change?
Over the past year, ANRO quarterly EBITDA has changed by $0.00 (0.00%)
What is Alto Neuroscience TTM EBITDA?
The current TTM EBITDA of ANRO is -$55.60 M
What is the all time high TTM EBITDA for Alto Neuroscience?
Alto Neuroscience all-time high TTM EBITDA is -$7.55 M
What is Alto Neuroscience TTM EBITDA year-on-year change?
Over the past year, ANRO TTM EBITDA has changed by $0.00 (0.00%)